Accelerating life sciences research

OpenAI and Retro Bio have developed the GPT-4b micro model, a specialized AI designed to enhance protein engineering for stem cell therapy and longevity research. This model's architecture is optimized for biological data, allowing for more effective protein design, which could significantly accelerate advancements in life sciences. The release of this model is crucial for practitioners seeking to leverage AI in biochemistry and therapeutic development.